NCT04335773 COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology
| NCT ID | NCT04335773 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Akershus |
| Condition | Pediatric Respiratory Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 350 participants |
| Start Date | 2020-04-03 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 350 participants in total. It began in 2020-04-03 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prospective cohort study of COVID-19 infection among children in Norway.
Eligibility Criteria
Inclusion Criteria: Suspected covid-19 infection and age 0-18 years Exclusion Criteria: Age \>18 years
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04335773 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Pediatric Respiratory Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04335773 currently recruiting?
Yes, NCT04335773 is actively recruiting participants. Contact the research team at chris.inchley@gmail.com for enrollment information.
Where is the NCT04335773 trial being conducted?
This trial is being conducted at Lørenskog, Norway.
Who is sponsoring the NCT04335773 clinical trial?
NCT04335773 is sponsored by University Hospital, Akershus. The trial plans to enroll 350 participants.